Li et al. revealed high GGT5 expression in CAFs of lung adenocarcinoma, where elevated GGT5 levels in CAFs contributed to cancer cell survival and drug resistance, predicting unfavorable survival in lung adenocarcinoma patients [13]. The gene discussed is GGT5; the disease is cancer.